Showing 441 - 460 results of 15,701 for search 'treating data', query time: 0.16s Refine Results
  1. 441
  2. 442
  3. 443

    Identification and validation of key target genes of penning formula for treating rat chronic endometritis model by Liu Zhihui, Shi Jiani, Chen Chen, Yuan Yuqiong, Chen Guorun, Zhou Qianru

    Published 2025-07-01
    “…Abstract This study analyzed transcriptome sequencing data from rat samples, categorized into control (normal), model (chronic endometritis, CE), and test (treated with Penning Formula, PNF) groups, to identify key target genes of PNF in CE treatment and elucidate the specific mechanism of PNF treatment for CE. …”
    Get full text
    Article
  4. 444

    Identification of the Role of Mume fructus in Treating Nocturnal Asthma Based on Network Pharmacology and In vitro Investigation by Ling-Ling Tang, Yan-Qiu Xu, Ying Yang, Xian-Hong Sun, Bo-Han Wang, Xiao-Lu Shi, Li Liu

    Published 2024-12-01
    “…This study evaluated the therapeutic mechanisms of Mume fructus in treating nocturnal asthma. Materials and Methods: Network pharmacology was used to investigate the chemical composition, critical targets, and potential mechanisms of action of Mume fructus in treating nocturnal asthma. …”
    Get full text
    Article
  5. 445
  6. 446
  7. 447
  8. 448

    Unilateral versus bilateral pedicle screw fixation for treating two-level lumbar degenerative diseases by Ke Yang, Dongwei Wu, Jianjun Kong, Xiangping Peng, Huarong Wu, Shaofeng Wang, Huiwang Wang, Xingtong Zhu, Zhanyong Wu, Sidong Yang

    Published 2025-07-01
    “…The clinical efficacy and radiological data were evaluated and compared. The UPSF group was significantly lower than the BPSF group regarding operation time, intraoperative blood loss, and hospitalization expenses. …”
    Get full text
    Article
  9. 449
  10. 450
  11. 451

    The role of Chinese herbal medicine in the regulation of oxidative stress in treating hypertension: from therapeutics to mechanisms by Zixuan Jin, Yu Lan, Junying Li, Pengqian Wang, Xingjiang Xiong

    Published 2024-10-01
    “…Methods To review the efficacy and mechanism by which CHM treat hypertension through targeting oxidative stress, data were searched from PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, the Chinese National Knowledge Infrastructure, the VIP Information Database, the Chinese Biomedical Literature Database, and the Wanfang Database from their inception up to January 2024. …”
    Get full text
    Article
  12. 452
  13. 453
  14. 454

    A novel external fixation for treating tibial fractures: a finite element and biomechanical study by Shen Liu, Xiangdang Liang, Songyang Liu, Zhanshe Guo, Xing Wei, Yonghui Liang

    Published 2025-03-01
    “…Verify the rationality and effectiveness of the device in treating tibial fractures through finite element analysis and biomechanical comparative tests. …”
    Get full text
    Article
  15. 455

    Using computational pharmacology and experimental verification to decode mechanism of Qing-Wei-San in treating periodontitis by Yanhong Liu, Wenqi Li, Jingxiao Chen, Yi Li, Jieqi Cai, Yongxi Luo, Jiahao Lin, Lu Chen, Aiping Lu, Daogang Guan, Huiyong Xu

    Published 2025-07-01
    “…Abstract Objective This study aims to identify the bioactive components of Qing-Wei-San (QWS) for treating periodontitis and to uncover their mechanisms using computational pharmacology. …”
    Get full text
    Article
  16. 456
  17. 457
  18. 458
  19. 459

    Latin American critical data studies by Rafael Grohmann

    Published 2025-06-01
    “…In recent years, critical data studies from the Global South have gained traction, generating debates on power, knowledge production, and the politics of data. …”
    Get full text
    Article
  20. 460

    Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab by Kirsten I. Taylor, Florian Lipsmeier, Marzia A. Scelsi, Ekaterina Volkova-Volkmar, Daria Rukina, Werner Popp, Stefan Lambrecht, Judith Anzures-Cabrera, David Summers, Markus Abt, Annabelle Monnet, Timothy Kilchenmann, Jens Schjodt-Eriksen, Laurent Essioux, Thomas Kustermann, Wagner Zago, Hanno Svoboda, Tania Nikolcheva, Ronald B. Postuma, Gennaro Pagano, Michael Lindemann, PASADENA Investigators, Prasinezumab Study Group

    Published 2025-06-01
    “…Change from baseline analyses censored data at dopaminergic treatment start. Bilateral speeded tapping variability and hand-turning, U-turn speed, passively monitored hand movement power, and summary Simple Sum scores progressed numerically less in prasinezumab-treated vs placebo at week 52. …”
    Get full text
    Article